Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

Asthmatic Volunteers 240729


Study Dates: 23/11/19 - 15/10/20

Trial Number

240729

Group

●  Asthma

Compensation

Up to: $4,820

Gender

Male, Female, Non-Smoker

Age

18-65

Additional Information

Cohort 3b

Admission to the unit - Wednesday 18th March 2020

Discharge from the unit - Thursday 2nd April 2020

Outpatient visit - Friday 3rd April 2020

Follow-up appointment - Friday 10th April 2020

Cohort 3c

Admission to the unit - Saturday 28th March 2020

Discharge from the unit - Sunday 12th April 2020

Outpatient visit - Monday 13th April 2020

Follow-up appointment - Monday 20th April 2020

Details

We are currently recruiting Mild Asthmatics who are using the Blue sulbutamol inhaler (Ventolin), only.

The study involves a stay of 15 nights in our unit with one outpatient visit and one follow up visits. Total duration of the study is 18 days.

Start dates are flexible so please call us to see if we can work around your calander.


The main purpose of the study is to see how safe the Study Drug is and how well it is tolerated after dosing.

The study will also investigate:

• How the Study Drug is taken up, metabolised (chemically broken down), distributed through the body and excreted, this is called the pharmacokinetics (PK) of the Study Drug.

• How the body is affected by the Study Drug, this is called the pharmacodynamics (PD) of the Study Drug.

• Try to understand why different people respond differently to the same drug through DNA testing (please refer to the separate informed consent form for genetic testing).The sponsor is developing the study drug as a treatment for asthma. Asthma is a chronic disease of the airways that makes breathing difficult. The study drug works by preventing the formation of certain proteins by the immune system, which cause inflammation (swelling), and so reducing the symptoms of asthma.


This is a first time in human study.